Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy including brachytherapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Elekta’s Series B share is listed on Nasdaq OMX Stockholm. Elekta employs 3800 highly skilled individuals in 24 countries and in the fiscal year 2013/14 posted sales of 10 700 MSEK.